I got in much earlier but I have bought some recently. Post successful placement they are funded for the start of upcoming trials due to start any day now.
It’s very early and obviously Pre approvals and pre revenue so lots of risk. But I see Nanosonic potential and similar great management and GE Healthcare connections.
NAN is 42 times the size of EMV and EMV May take a similar path. Always difficult with an entry point but with a 5 to 10 year view providing trials go well I think it won’t matter to much if the timing is not exactly right. It’s tightly held and well managed. The device looks like it meets a large unmet need driven by clinical demand and has other variations going forward.
DYOR and not advice - this is getting in on the ground floor and carries those serious risks / rewards.
I got in much earlier but I have bought some recently. Post...
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.99 |
Change
0.040(1.36%) |
Mkt cap ! $905.9M | |||
| Open | High | Low | Value | Volume |
| $2.98 | $3.04 | $2.96 | $3.563M | 1.185M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 18897 | $2.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.01 | 7344 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NAN (ASX) Chart |